Cleared Traditional

K140923 - TRACTION POLYPECTOMY SNARE (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K140923 · Ovesco Endoscopy AG · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2014
Decision
222d
Days
Class 2
Risk

K140923 is an FDA 510(k) clearance for the TRACTION POLYPECTOMY SNARE. Classified as Snare, Flexible (product code FDI), Class II - Special Controls.

Submitted by Ovesco Endoscopy AG (Tuebingen, Baden-Wuerttemberg, DE). The FDA issued a Cleared decision on November 18, 2014 after a review of 222 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4300 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ovesco Endoscopy AG devices

Submission Details

510(k) Number K140923 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 2014
Decision Date November 18, 2014
Days to Decision 222 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 130d · This submission: 222d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FDI Snare, Flexible
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FDI Snare, Flexible

All 62
Devices cleared under the same product code (FDI) and FDA review panel - the closest regulatory comparables to K140923.
Advanced Tissue Resection Device
K251692 · Micro-Tech (Nanjing) Co., Ltd. · Feb 2026
Polypectomy Snare
K221713 · Hangzhou AGS MedTech Co., Ltd. · Mar 2023
CORE-SNARE
K220846 · Incore Co., Ltd. · Nov 2022
Disposable Polyp Snare
K220089 · Jiangsu Vedkang Medical Science and Technology Co., Ltd. · Sep 2022
Disposable Polypectomy Snare, Disposable Polypectomy Hybrid Snare
K220790 · Yangzhou Fartley Medical Instrument Technology Co., Ltd. · Jun 2022
Disposable Polypectomy Snare
K213222 · Beijing Zksk Technology Co., Ltd. · Jun 2022